Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical Carcinoma
West China Hospital
West China Hospital
Instituto do Cancer do Estado de São Paulo
Fundación de investigación HM
Wuerzburg University Hospital
Dartmouth-Hitchcock Medical Center
Stanford University